Facial Lipoatrophy: Appearances Are Not Deceiving

Journal of the Association of Nurses in AIDS Care

Volumn 20, Issue 3, 2009, Pages 169-175

  Sanches, Roberta Seron ^a   Mill, Judy ^a   Machado, Alcyone Artioli ^a   Donadi, Eduardo Antonio ^a   Morais Fernandes, Ana Paula ^a  

^a NONE

Author keywords

antiretroviral therapy; Brazil; HIV; lipodystrophy; nursing; psychosocial

Indexed keywords

ADULT; ARTICLE; BRAZIL; CROSS-SECTIONAL STUDY; FACE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; MALE; MIDDLE AGED; PATHOLOGY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SELF CONCEPT;

ADULT; BRAZIL; CROSS-SECTIONAL STUDIES; FACE; FEMALE; HIV INFECTIONS; HUMANS; LIPODYSTROPHY; MALE; MIDDLE AGED; QUESTIONNAIRES; SELF CONCEPT;

EID: 65449121550     PISSN: 10553290     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jana.2009.01.002     Document Type: Article

References (25)

1. Bernasconi E., Boubaker K., Junghans C., Flepp M., Furer H., Haensel A., et al. Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs. Journal of Acquired Immune Deficiency Syndromes 31 (2002) 50
2. Blanch J., Rousaud A., Martinez E., De Lazzari E., Milinkovic A., Peri J., et al. Factors associated with severe impact of lipodystrophy on the quality of life of patients infected with HIV-1. Clinical Infectious Diseases 38 (2004) 1464-1470
3. Blanch J., Rousaud A., Martinez E., De Lazzari E., Peri J., Milinkovic A., et al. Impact of lipodystrophy on the quality of life of HIV-1-infected patients. Journal of Acquired Immune Deficiency Syndromes 31 (2002) 404
4. Bourgoyne R., Collins E., Wagner C., Abbey S., Halman M., Nur M., et al. The relationship between lipodystrophy-associated bodily changes and measures of quality of life and mental health for HIV-positive adults. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care, and Rehabilitation 14 (2005) 981-990
5. Brazilian Ministry of Health. Targets and commitments made by the member-states at the United Nations General Assembly Special Session on HIV/AIDS: Brazilian response 2005-2007 country progress report (2008), Health Surveillance Secretariat, National STD and AIDS Programme, Brazil
6. Brink P.J., and Wood M.J. Advanced design in nursing research. 2nd ed. (1998), Sage Publications, Thousand Oaks, CA
7. Carr A. Treatment strategies for HIV lipodystrophy. Current Opinion in HIV and AIDS 2 (2008) 332-338
8. Collins E., Wagner C., and Walmsley S. Psychosocial impact of the lipodystrophy syndrome in HIV infection. The AIDS Reader 10 (2000) 546-550
9. Castilho E.A., and Kalil J. Ethics and medical research: Principles, guidelines, and regulations. Revista da Sociedade Brasileira de Medicina Tropical 38 (2005) 344-347
10. De Wit S., Sabin C.A., Weber R., Worm S.W., Reiss P., Cazanave C., et al. Incidence and risk factors for new-onset diabetes in HIV-infected patients: The Data Collection on Adverse Events of Anti-HIV Drugs (D: A:D) Study. Diabetes Care 31 (2008) 1224-1229
11. Doward L.C., Dietz B., Wilburn J., McKenna S.P., Bhor M., and Rajagopalan R. Impact of lipoatrophy on patient-reported outcomes in antiretroviral experienced patients. AIDS Reader 18 (2008) 242
12. Duran S., Saves M., Spire B., Cailleton V., Sobel A., Carrieri P., et al. Failure to maintain long-term adherence to highly active antiretroviral therapy: The role of lipodystrophy. AIDS 15 (2001) 2441-2444
13. Green M.L. Evaluation and management of dyslipidemia in patients with HIV infection. Journal of General Internal Medicine 17 (2002) 797-810
14. Guaraldi G., Murri R., Orlando G., Orlandi E., Sterrantino G., Borderi M., et al. Morphologic alterations in HIV-infected people with lipodystrophy are associated with good adherence to HAART. HIV Clinical Trials 4 (2003) 99-106
15. Huang J.S., Lee D., Becerra R., Santos R., Barber E., and Mathews C. Body image in men with HIV. AIDS Patient Care and STDs 20 (2006) 668-677
16. Joint United Nations Programme on HIV/AIDS. (2008). 2008 Report on the global AIDS epidemic. UNAIDS. Retrieved December 10, 2008, from http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/
17. Jones D. Approaches to treatment of HIV facial lipoatrophy. Skin Therapy Letter 10 (2005) 5-7
18. Kotler D.P. HIV lipodystrophy etiology and pathogenesis. Body composition and metabolic alterations: Etiology and pathogenesis. The AIDS Reader 13 (2003) S5-S9
19. Kotler D.P. HIV and antiretroviral therapy: Lipid abnormalities and associated cardiovascular risk in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes 49 (2008) 79-85
20. Martinez E., Garcia-Viejo M.A., Blanch J., and Gatell J. Lipodystrophy syndrome in patients with HIV infection. Drug Safety 24 (2001) 157-166
21. Negredo E., Higueras C., Adell X., Martinez J.C., Martinez E., Puig J., et al. Reconstructive treatment for antiretroviral-associated facial lypoatrophy: A prospective study comparing autologous fat and synthetic substances. AIDS Patient Care and STDs 20 (2006) 829-837
22. Okie S. Fighting HIV-Lessons from Brazil. The New England Journal of Medicine 354 (2006) 1977-1981
23. Peterson S., Martins C.R., and Cofrancesco J.R. Lipodystrophy in the patient with HIV: Social, psychosocial, and treatment considerations. Aesthetic Surgery Journal 28 (2008) 443-451
24. Power R., Tate H.L., McGill S.M., and Taylor C. A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals. Sexually Transmitted Infections 79 (2003) 137
25. Sattler F.R. Pathogenesis and treatment of lipodystrophy: What clinicians need to know. Topics in HIV Medicine 16 (2008) 127-133